Daniel Joseph Apel
Chief Financial Officer · ARROWHEAD PHARMACEUTICALS, INC.
- 2026
- Apr 24, 2026
- 1
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Daniel Joseph Apel files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Christopher Richard Anzalone - $12.35M in ARWR purchases and sales in the last 12 months
- James C. Hamilton - $1.39M in ARWR purchases and sales in the last 12 months
- Michael S. Perry - $1.01M in ARWR purchases and sales in the last 12 months
- Mauro Ferrari - $493K in ARWR purchases and sales in the last 12 months
- Hongbo Lu - $228K in ARWR purchases and sales in the last 12 months
- Adeoye Y. Olukotun - $174K in ARWR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Daniel Joseph Apel?
Daniel Joseph Apel is a corporate insider, tracked as Chief Financial Officer of ARROWHEAD PHARMACEUTICALS, INC. (ARWR). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Daniel Joseph Apel last file a Form 4?
The only primary Form 4 on record is dated 24 April 2026.
Has Daniel Joseph Apel been buying or selling stock?
Recorded transactions: 0 open-market purchases and 3 open-market sales ($934K) across all tracked filings.
